From: Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
Group
Total no. of patients
Age
(mean ± S.D.)
Median Ccf nDNA(GE/mL)
Median Ccf mtDNA (GE/mL)
Malignant disease group
52
64 ± 15
4678
205013
Benign disease group
26
41 ± 16
1359
73977
Control group
70
53 ± 14.6
1298
522115